🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Serum KL-6 protein has been described as a biomarker of epithelial lung inj...
Status
Unknown
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01437956
The research study is to explore novel early predictors and validation of l...
Status
Unknown
Location
National University Hospital, Singapore
Start Date
2020-11-25
Trial ID
NCT04624945
The aim of this study is to investigate the diagnostic and prognostic value...
Status
Completed
Location
Hospital of Southern Jutland
Start Date
2021-03-01
Trial ID
NCT04686331
Treatments Being Tested
The purpose of the study is to evaluate the significance of KL-6 as a bioma...
Status
Completed
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT02197364
Diffuse Parenchymal Lung Disease(DPLD) is a chronic progressive fibrosis lu...
Status
Unknown
Location
First Affiliated Hospital of Guangzhou Medical university
Start Date
2013-02
Trial ID
NCT03101397
Evaluation of serum KL6 level in rheumatoid arthritis-associated interstiti...
Status
Unknown
Location
Safaa A Eid
Start Date
2023-01-01
Trial ID
NCT05979454
Treatments Being Tested
A group of Interstitial pulmonary fibrosis will be recruited from Assiut un...
Status
Completed
Location
Faculty of Medicine, Assiut University
Start Date
2023-09-01
Trial ID
NCT06539962
Treatments Being Tested
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease with a poor p...
Status
Unknown
Location
Manchester University hospitals NHS Foundation Trust
Start Date
2021-02-01
Trial ID
NCT04268485
Treatments Being Tested
Interstitial lung disease is a chronic progressive fibrosis lung disease th...
Status
Unknown
Location
Ying Jiang
Start Date
2013-03
Trial ID
NCT02960672
COVID-19 causes a wide spectrum of clinical illness, from upper respiratory...
Status
Completed
Location
Haseki Training and Research Hospital
Start Date
2021-07-01
Trial ID
NCT05619640